Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.56
0.06 (1.71%)
At close: Jun 18, 2025, 3:59 PM
3.54
-0.70%
After-hours: Jun 18, 2025, 04:47 PM EDT
1.71% (1D)
| Bid | 3.48 |
| Market Cap | 936.3M |
| Revenue (ttm) | 184.91M |
| Net Income (ttm) | -45.31M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -16.98 |
| Forward PE | 50.86 |
| Analyst | Buy |
| Ask | 3.58 |
| Volume | 3,301,350 |
| Avg. Volume (20D) | 5,438,236 |
| Open | 3.50 |
| Previous Close | 3.50 |
| Day's Range | 3.48 - 3.62 |
| 52-Week Range | 0.80 - 4.08 |
| Beta | 0.84 |
About AKBA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKBA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKBA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+6.5%
Akebia Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
-28.17%
Akebia Therapeutics shares are trading lower after the company announced the pricing of a $50 million offering of 25 million common shares at $2/share.
1 month ago · seekingalpha.com
Akebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call TranscriptAkebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Mercedes Carrasco - Senior Director of Investor Relations John Butler - Chief Exec...
